Phase II study of selumetinib (AZD6244, ARRY-142886) plus...

Cancer Chemotherapy and Pharmacology 2015 / 1 Vol. 75; Iss. 1

Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer

Hochster, H. S., Uboha, N., Messersmith, W., Gold, P. J., ONeil, B. H., Cohen, D., Denlinger, C., Cohen, S., Leichman, C. G., Leichman, L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
75
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-014-2609-3
Date:
January, 2015
File:
PDF, 223 KB
english, 2015
Conversion to is in progress
Conversion to is failed